TIG Advisors’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
Other funds holding AMED
TIG Advisors's AMED Position: Q3 2025 in Review
TIG Advisors sold out of Amedisys (AMED) in Q3 2025, closing a stake of 856,753 shares — an estimated $84.3M sold.
TIG Advisors first reported a position in AMED in Q2 2023 and held it in 5 quarters. The position peaked at $84.3M in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.
- TIG Advisors reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
- TIG Advisors sold 856,753 Amedisys shares in Q3 2025, an estimated $84.3M.
- TIG Advisors first reported a position in Amedisys in Q2 2023 and held it in 5 quarters.
- TIG Advisors's Amedisys position peaked at $84.3M in Q2 2025.
- 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.
Based on TIG Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.